CN Stock MarketDetailed Quotes

603193 Runben Biotechnology

Watchlist
  • 22.36
  • +0.79+3.66%
Not Open Nov 29 15:00 CST
9.05BMarket Cap29.54P/E (TTM)

Runben Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Assets
Current assets
Money funds
-71.78%129.41M
-36.75%259.18M
--104.74M
-33.78%243.83M
--458.6M
60.55%409.79M
78.58%368.21M
--255.25M
421.63%206.19M
27.02%39.53M
Transactional financial assets
185.78%266.92M
61.76%134.6M
--27.64M
130.64%19M
--93.4M
-13.49%83.21M
-85.35%8.24M
--96.19M
33.35%56.24M
883.39%42.17M
Notes receivable and accounts receivable
86.91%15.78M
563.93%39.58M
--12.36M
303.46%4.82M
--8.44M
-19.43%5.96M
-49.03%1.19M
--7.4M
-15.59%2.34M
-16.65%2.78M
-Accounts receivable
86.91%15.78M
563.93%39.58M
--12.36M
303.46%4.82M
--8.44M
-19.43%5.96M
-49.03%1.19M
--7.4M
-15.59%2.34M
-16.65%2.78M
Other receivables (including interest and dividends)
-11.87%3.2M
75.46%3.87M
--2.46M
-61.30%2.3M
--3.63M
28.15%2.21M
326.97%5.94M
--1.72M
-0.82%1.39M
16.52%1.4M
-Dividend receivable
----
----
----
----
--0
----
----
----
----
----
-Accrued interest receivable
----
----
----
----
--0
----
----
----
----
----
-Other receivable
----
75.46%3.87M
----
----
--3.63M
28.15%2.21M
326.97%5.94M
--1.72M
-0.82%1.39M
16.52%1.4M
Advance payment
4.88%11.89M
-23.29%9.37M
--15.93M
8.61%8.31M
--11.34M
6.69%12.22M
-32.80%7.65M
--11.45M
250.20%11.39M
27.25%3.25M
Inventories
22.19%123.43M
23.68%166.25M
--141.06M
-9.54%92.91M
--101.02M
20.47%134.42M
80.52%102.71M
--111.58M
25.82%56.9M
52.90%45.22M
Other current assets
89,517.84%1.31B
14,180.24%1.3B
--1.45B
8,258.92%1.35B
--1.46M
15,178.26%9.1M
62.39%16.09M
--59.58K
32.78%9.91M
332.19%7.46M
Total current assets
174.05%1.86B
191.16%1.91B
--1.76B
236.51%1.72B
--677.88M
35.82%656.91M
48.12%510.04M
--483.64M
142.82%344.36M
92.16%141.82M
Non Current assets
Fixed assets
----
-4.23%249.57M
----
----
----
31.04%260.6M
38.76%264.24M
--198.87M
283.00%190.43M
-8.27%49.72M
Fixed assets liquidation
----
----
----
----
----
----
----
----
----
--1.67K
Constru in process
----
145.88%7.94M
----
----
----
-95.07%3.23M
-19.57%5.76M
--65.48M
-87.85%7.17M
349.03%59.01M
Productive biological assets
----
----
----
----
--0
----
----
----
----
----
Intangible assets
-3.39%18.26M
-3.42%18.43M
--18.59M
-3.13%18.76M
--18.9M
-3.23%19.08M
-2.61%19.36M
--19.71M
-3.21%19.88M
-2.64%20.54M
Development expenditure
----
----
----
----
--0
----
----
----
----
----
Long deferred expense
-3.15%1.3M
-2.87%1.34M
--1.38M
--1.41M
--1.34M
--1.38M
----
----
----
----
Deferred tax assets
128.51%41.61M
82.14%40.81M
--25.92M
40.71%20.82M
--18.21M
79.73%22.41M
161.34%14.8M
--12.47M
136.91%5.66M
15.66%2.39M
Usufruct assets
-25.91%3.07M
-26.92%3.41M
--3.75M
-50.60%3.73M
--4.14M
-47.07%4.67M
-25.00%7.56M
--8.82M
--10.08M
----
Other non current assets
546.78%36.62M
----
--1.29M
-69.20%1.13M
--5.66M
7.87%3.42M
-94.69%3.65M
--3.17M
2,200.57%68.77M
2,357.11%2.99M
Total non current assets
16.80%360.68M
2.13%321.49M
--306.44M
-4.07%302.54M
--308.81M
2.03%314.77M
4.44%315.38M
--308.52M
124.27%301.98M
48.57%134.65M
Total assets
124.84%2.22B
129.93%2.23B
--2.07B
144.59%2.02B
--986.69M
22.66%971.68M
27.71%825.42M
--792.16M
133.79%646.34M
68.14%276.47M
Liabilities
Current liabilities
Notes payable and accounts payable
25.35%49.31M
82.01%134.53M
--69.35M
10.67%52.71M
--39.34M
-11.84%73.92M
2.72%47.63M
--83.84M
249.58%46.37M
-6.40%13.27M
-Accounts payable
25.35%49.31M
82.01%134.53M
--69.35M
10.67%52.71M
--39.34M
-11.84%73.92M
2.72%47.63M
--83.84M
249.58%46.37M
-6.40%13.27M
Contract liabilities
11.40%3.25M
-18.22%4.51M
--2.63M
32.51%5.97M
--2.92M
83.48%5.52M
7.18%4.5M
--3.01M
22.28%4.2M
--3.44M
Salaries payable
19.82%12.98M
11.25%13.14M
--9.75M
18.18%12.78M
--10.83M
8.97%11.81M
48.13%10.82M
--10.84M
43.70%7.3M
47.65%5.08M
Taxs payable
53.42%33.94M
45.27%43.09M
--20.86M
-33.32%19.26M
--22.12M
-29.67%29.66M
207.70%28.88M
--42.18M
504.16%9.38M
31.62%1.55M
Other payable (including interest and dividends)
5,656.94%73.95M
10.69%1.28M
--1.11M
7.21%1.6M
--1.28M
-14.64%1.15M
-67.90%1.49M
--1.35M
800.51%4.66M
-82.07%517K
-Dividend payable
--72.83M
----
----
----
----
----
----
----
--3.44M
----
-Other payable
--1.12M
10.69%1.28M
----
----
----
-14.64%1.15M
22.85%1.49M
--1.35M
135.32%1.22M
-82.07%517K
Non current liabilities due within one year
-29.05%1.35M
-26.93%1.34M
--1.33M
-22.27%1.95M
--1.9M
-25.45%1.83M
4.75%2.51M
--2.46M
--2.4M
----
Other current liabilities
1.74%422.73K
17.00%846.53K
--341.68K
11.09%842.18K
--415.51K
44.71%723.52K
-36.57%758.09K
--499.99K
218.74%1.2M
--374.97K
Total current liabilities
122.30%175.2M
59.48%198.74M
--105.36M
-1.53%95.12M
--78.81M
-13.56%124.62M
27.92%96.6M
--144.17M
211.66%75.52M
-4.19%24.23M
Current liabilities
Deferred tax liabilities
-25.37%343.54K
-21.02%399.35K
--388.49K
-23.53%435.64K
--460.34K
3,295.05%505.65K
295.46%569.69K
--14.89K
165.87%144.06K
--54.18K
Long term deferred income
-21.43%9.31K
-54.82%9.94K
--10.58K
-95.87%11.21K
--11.85K
-96.70%22.01K
-75.91%271.51K
--667.83K
-44.91%1.13M
14.89%2.05M
Lease liabilities
-29.70%1.76M
-32.75%2.11M
--2.45M
-62.13%2.04M
--2.51M
-53.02%3.13M
-31.80%5.39M
--6.67M
--7.91M
----
Other non current liabilities
----
----
----
----
--0
----
----
----
----
----
Total non current liabilities
-29.00%2.12M
-31.27%2.52M
--2.84M
-60.08%2.49M
--2.98M
-50.20%3.66M
-32.08%6.23M
--7.35M
337.06%9.18M
17.93%2.1M
Total liabilities
116.79%177.32M
56.89%201.26M
--108.21M
-5.08%97.61M
--81.79M
-15.34%128.28M
21.42%102.83M
--151.52M
221.67%84.69M
-2.74%26.33M
Shareholders equity
Paid-in capital
17.65%404.59M
17.65%404.59M
--404.59M
17.65%404.59M
--343.9M
0.00%343.9M
0.00%343.9M
--343.9M
233.66%343.9M
71.79%103.07M
Capital reserve funds
874.54%1.02B
876.45%1.01B
--1.01B
888.93%1.01B
--104.16M
1.76%103.94M
0.88%102.59M
--102.14M
-13.29%101.69M
1,659.20%117.28M
Surplus reserve funds
75.76%62.62M
37.41%48.96M
--48.96M
37.41%48.96M
--35.63M
66.95%35.63M
66.95%35.63M
--21.34M
132.15%21.34M
143.25%9.19M
Retained profit
32.66%558.78M
56.81%564.41M
--488.63M
88.45%453.16M
--421.2M
107.75%359.93M
153.90%240.46M
--173.25M
359.78%94.71M
-69.22%20.6M
Shareholders equity without minority interests
125.56%2.04B
141.03%2.03B
--1.96B
165.89%1.92B
--904.89M
31.65%843.41M
28.66%722.59M
--640.64M
124.53%561.65M
82.10%250.14M
Total shareholder equity
125.56%2.04B
141.03%2.03B
--1.96B
165.89%1.92B
--904.89M
31.65%843.41M
28.66%722.59M
--640.64M
124.53%561.65M
82.10%250.14M
Total liabilityies and equity
124.84%2.22B
129.93%2.23B
--2.07B
144.59%2.02B
--986.69M
22.66%971.68M
27.71%825.42M
--792.16M
133.79%646.34M
68.14%276.47M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
Unqualified opinion
--
Unqualified opinion
Unqualified opinion
Auditor
--
--
--
Guangdong Sinong Accounting Firm (Special General Partnership)
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
Rong Cheng Certified Public Accountants (Special General Partnership)
Rong Cheng Certified Public Accountants (Special General Partnership)
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Assets
Current assets
Money funds -71.78%129.41M-36.75%259.18M--104.74M-33.78%243.83M--458.6M60.55%409.79M78.58%368.21M--255.25M421.63%206.19M27.02%39.53M
Transactional financial assets 185.78%266.92M61.76%134.6M--27.64M130.64%19M--93.4M-13.49%83.21M-85.35%8.24M--96.19M33.35%56.24M883.39%42.17M
Notes receivable and accounts receivable 86.91%15.78M563.93%39.58M--12.36M303.46%4.82M--8.44M-19.43%5.96M-49.03%1.19M--7.4M-15.59%2.34M-16.65%2.78M
-Accounts receivable 86.91%15.78M563.93%39.58M--12.36M303.46%4.82M--8.44M-19.43%5.96M-49.03%1.19M--7.4M-15.59%2.34M-16.65%2.78M
Other receivables (including interest and dividends) -11.87%3.2M75.46%3.87M--2.46M-61.30%2.3M--3.63M28.15%2.21M326.97%5.94M--1.72M-0.82%1.39M16.52%1.4M
-Dividend receivable ------------------0--------------------
-Accrued interest receivable ------------------0--------------------
-Other receivable ----75.46%3.87M----------3.63M28.15%2.21M326.97%5.94M--1.72M-0.82%1.39M16.52%1.4M
Advance payment 4.88%11.89M-23.29%9.37M--15.93M8.61%8.31M--11.34M6.69%12.22M-32.80%7.65M--11.45M250.20%11.39M27.25%3.25M
Inventories 22.19%123.43M23.68%166.25M--141.06M-9.54%92.91M--101.02M20.47%134.42M80.52%102.71M--111.58M25.82%56.9M52.90%45.22M
Other current assets 89,517.84%1.31B14,180.24%1.3B--1.45B8,258.92%1.35B--1.46M15,178.26%9.1M62.39%16.09M--59.58K32.78%9.91M332.19%7.46M
Total current assets 174.05%1.86B191.16%1.91B--1.76B236.51%1.72B--677.88M35.82%656.91M48.12%510.04M--483.64M142.82%344.36M92.16%141.82M
Non Current assets
Fixed assets -----4.23%249.57M------------31.04%260.6M38.76%264.24M--198.87M283.00%190.43M-8.27%49.72M
Fixed assets liquidation --------------------------------------1.67K
Constru in process ----145.88%7.94M-------------95.07%3.23M-19.57%5.76M--65.48M-87.85%7.17M349.03%59.01M
Productive biological assets ------------------0--------------------
Intangible assets -3.39%18.26M-3.42%18.43M--18.59M-3.13%18.76M--18.9M-3.23%19.08M-2.61%19.36M--19.71M-3.21%19.88M-2.64%20.54M
Development expenditure ------------------0--------------------
Long deferred expense -3.15%1.3M-2.87%1.34M--1.38M--1.41M--1.34M--1.38M----------------
Deferred tax assets 128.51%41.61M82.14%40.81M--25.92M40.71%20.82M--18.21M79.73%22.41M161.34%14.8M--12.47M136.91%5.66M15.66%2.39M
Usufruct assets -25.91%3.07M-26.92%3.41M--3.75M-50.60%3.73M--4.14M-47.07%4.67M-25.00%7.56M--8.82M--10.08M----
Other non current assets 546.78%36.62M------1.29M-69.20%1.13M--5.66M7.87%3.42M-94.69%3.65M--3.17M2,200.57%68.77M2,357.11%2.99M
Total non current assets 16.80%360.68M2.13%321.49M--306.44M-4.07%302.54M--308.81M2.03%314.77M4.44%315.38M--308.52M124.27%301.98M48.57%134.65M
Total assets 124.84%2.22B129.93%2.23B--2.07B144.59%2.02B--986.69M22.66%971.68M27.71%825.42M--792.16M133.79%646.34M68.14%276.47M
Liabilities
Current liabilities
Notes payable and accounts payable 25.35%49.31M82.01%134.53M--69.35M10.67%52.71M--39.34M-11.84%73.92M2.72%47.63M--83.84M249.58%46.37M-6.40%13.27M
-Accounts payable 25.35%49.31M82.01%134.53M--69.35M10.67%52.71M--39.34M-11.84%73.92M2.72%47.63M--83.84M249.58%46.37M-6.40%13.27M
Contract liabilities 11.40%3.25M-18.22%4.51M--2.63M32.51%5.97M--2.92M83.48%5.52M7.18%4.5M--3.01M22.28%4.2M--3.44M
Salaries payable 19.82%12.98M11.25%13.14M--9.75M18.18%12.78M--10.83M8.97%11.81M48.13%10.82M--10.84M43.70%7.3M47.65%5.08M
Taxs payable 53.42%33.94M45.27%43.09M--20.86M-33.32%19.26M--22.12M-29.67%29.66M207.70%28.88M--42.18M504.16%9.38M31.62%1.55M
Other payable (including interest and dividends) 5,656.94%73.95M10.69%1.28M--1.11M7.21%1.6M--1.28M-14.64%1.15M-67.90%1.49M--1.35M800.51%4.66M-82.07%517K
-Dividend payable --72.83M------------------------------3.44M----
-Other payable --1.12M10.69%1.28M-------------14.64%1.15M22.85%1.49M--1.35M135.32%1.22M-82.07%517K
Non current liabilities due within one year -29.05%1.35M-26.93%1.34M--1.33M-22.27%1.95M--1.9M-25.45%1.83M4.75%2.51M--2.46M--2.4M----
Other current liabilities 1.74%422.73K17.00%846.53K--341.68K11.09%842.18K--415.51K44.71%723.52K-36.57%758.09K--499.99K218.74%1.2M--374.97K
Total current liabilities 122.30%175.2M59.48%198.74M--105.36M-1.53%95.12M--78.81M-13.56%124.62M27.92%96.6M--144.17M211.66%75.52M-4.19%24.23M
Current liabilities
Deferred tax liabilities -25.37%343.54K-21.02%399.35K--388.49K-23.53%435.64K--460.34K3,295.05%505.65K295.46%569.69K--14.89K165.87%144.06K--54.18K
Long term deferred income -21.43%9.31K-54.82%9.94K--10.58K-95.87%11.21K--11.85K-96.70%22.01K-75.91%271.51K--667.83K-44.91%1.13M14.89%2.05M
Lease liabilities -29.70%1.76M-32.75%2.11M--2.45M-62.13%2.04M--2.51M-53.02%3.13M-31.80%5.39M--6.67M--7.91M----
Other non current liabilities ------------------0--------------------
Total non current liabilities -29.00%2.12M-31.27%2.52M--2.84M-60.08%2.49M--2.98M-50.20%3.66M-32.08%6.23M--7.35M337.06%9.18M17.93%2.1M
Total liabilities 116.79%177.32M56.89%201.26M--108.21M-5.08%97.61M--81.79M-15.34%128.28M21.42%102.83M--151.52M221.67%84.69M-2.74%26.33M
Shareholders equity
Paid-in capital 17.65%404.59M17.65%404.59M--404.59M17.65%404.59M--343.9M0.00%343.9M0.00%343.9M--343.9M233.66%343.9M71.79%103.07M
Capital reserve funds 874.54%1.02B876.45%1.01B--1.01B888.93%1.01B--104.16M1.76%103.94M0.88%102.59M--102.14M-13.29%101.69M1,659.20%117.28M
Surplus reserve funds 75.76%62.62M37.41%48.96M--48.96M37.41%48.96M--35.63M66.95%35.63M66.95%35.63M--21.34M132.15%21.34M143.25%9.19M
Retained profit 32.66%558.78M56.81%564.41M--488.63M88.45%453.16M--421.2M107.75%359.93M153.90%240.46M--173.25M359.78%94.71M-69.22%20.6M
Shareholders equity without minority interests 125.56%2.04B141.03%2.03B--1.96B165.89%1.92B--904.89M31.65%843.41M28.66%722.59M--640.64M124.53%561.65M82.10%250.14M
Total shareholder equity 125.56%2.04B141.03%2.03B--1.96B165.89%1.92B--904.89M31.65%843.41M28.66%722.59M--640.64M124.53%561.65M82.10%250.14M
Total liabilityies and equity 124.84%2.22B129.93%2.23B--2.07B144.59%2.02B--986.69M22.66%971.68M27.71%825.42M--792.16M133.79%646.34M68.14%276.47M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion----Unqualified opinion--Unqualified opinionUnqualified opinion
Auditor ------Guangdong Sinong Accounting Firm (Special General Partnership)----Rong Cheng Certified Public Accountants (Special General Partnership)--Rong Cheng Certified Public Accountants (Special General Partnership)Rong Cheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data